Stay updated with breaking news from Total Maximal Chorea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO - Neurocrine Biosciences, Inc. today announced interim results from the ongoing open-label KINECT-HD2 study about INGREZZA capsules when used for the long-term treatment of adults with...
Ingrezza has demonstrated consistently greater improvements in adults with chorea associated with HD from week 2 to 12 vs placebo.
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data on now FDA-approved INGREZZA® (valbenazine) capsules for the treatment of...
Ingrezza has demonstrated consistently greater improvements in adults with chorea associated with HD from week 2 to 12 vs placebo.
The FDA has approved Ingrezza (valbenazine) for the treatment of adults with chorea associated with Huntington disease.